WebDo not receive APRETUDE if you: already have HIV-1 or do not know your HIV-1 status. If you are HIV-1 positive, you need to take other medicines to treat HIV-1. APRETUDE can only help reduce your risk of getting HIV-1 infection before you are infected. If you have HIV-1 and receive only APRETUDE, over time, your HIV-1 may become harder to treat WebDec 21, 2024 · Apretude is an HIV-1 integrase strand transfer inhibitor (INSTI) indicated in at-risk adults and adolescents weighing at least 35 kg for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 infection. Individuals must have a negative HIV-1 test prior to initiating Apretude (with or without an oral lead-in with oral ...
Long-acting PrEP APRETUDE (cabotegravir)
WebDec 20, 2024 · APRETUDE is an HIV-1 integrase strand transfer inhibitor (INSTI) indicated in at-risk adults and adolescents weighing at least 35 kg for PrEP to reduce the risk of sexually acquired HIV-1 infection. Individuals must have a negative HIV-1 test prior to initiating APRETUDE (with or without an oral lead-in with oral cabotegravir) for HIV-1 PrEP. WebApr 1, 2024 · Position Overview. ViiV Healthcare is seeking an experienced, results-driven professional in Specialty Sales for the position of Territory Account Manager (TAM) on the Apretude Preventative Injectable Treatment Sales team. The ability to thrive in a fast-paced, complex environment and work with HCPs to adopt a new approach to HIV prevention ... la pena baiona 2022
FDA Approves First Injectable Treatment for HIV Pre …
WebDec 21, 2024 · Trial 2 included uninfected cisgender women at risk of acquiring HIV. Participants who took Apretude started the trial with cabotegravir (oral, 30 mg tablet) and a placebo daily for up to five ... WebJun 30, 2024 · Apretude is a prescription medicine used for HIV-1 PrEP to reduce the risk of getting HIV-1 infection in adults and adolescents who weigh at least 77 pounds (at least 35 kg). HIV-1 is the virus that causes Acquired Immune Deficiency Syndrome (AIDS). WebJun 30, 2024 · Apretude (cabotegravir extended-release injection) is a long-acting injection for HIV pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 … la pena baiona youtube